Old Web
English
Sign In
Acemap
>
authorDetail
>
Zhao-Chong Zeng
Zhao-Chong Zeng
Fudan University Shanghai Medical College
Cancer
Medicine
Hepatocellular carcinoma
Radioimmunotherapy
Ligation
5
Papers
98
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials
1998
Journal of Cancer Research and Clinical Oncology
Zhao-Chong Zeng
Zhao-You Tang
Kang-Da Liu
Ji-Zhen Lu
Hong Xie
Zhen Yao
Show All
Source
Cite
Save
Citations (26)
Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection
1995
World Journal of Surgery
Zhao-You Tang
Ye Qin Yu
Xin-Da Zhou
Zeng-Chen Ma
Bing-Hui Yang
Zhi-Ying Lin
Ji-Zhen Lu
Kang-Da Liu
Zeng Fan
Zhao-Chong Zeng
Show All
Source
Cite
Save
Citations (31)
Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion
1994
Cancer Immunology, Immunotherapy
Zhao-Chong Zeng
Zhao-You Tang
Kang-Da Liu
Ji-Zhen Lu
Xiao-Jie Cai
Hong Xie
Show All
Source
Cite
Save
Citations (12)
Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results
1993
Journal of Cancer Research and Clinical Oncology
Zhao-Chong Zeng
Zhao-You Tang
Hong Xie
Kang-Da Liu
Ji-Zen Lu
Xiao-Jie Chai
Gen-Fen Wang
Zen Yao
Jia-mo Qian
Show All
Source
Cite
Save
Citations (22)
1